Lineage Cell Therapeutics (LCTX) Stock: Buy, Sell, or Hold?

LCTX - Lineage Cell Therapeutics, Inc.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$1.01
-0.02 (-1.94%) ▼
5d: +0.0%
30d: -8.18%
90d: -16.53%
BUY
HIGH Confidence
Analysis Updated: Sep 17, 2026 12:00 AM ET
Earnings: Nov 05, 2026

Get Alerted When LCTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: LCTX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: LCTX is currently trading at $1.01, which is considered fair relative to its 30-day fair value range of $1.05 to $1.12.

Technical Outlook: Technically, LCTX is in a strong uptrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: LCTX scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+434.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $1.05 - $1.12
Company Quality Score 63/100 (BUY)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (73/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 434.0% below Wall St target ($5.50)
  • BULLISH: Bottoming setup score 73/100 — corrected, stabilizing, and turning up

Trading Range Analysis

30-Day Trading Range $1.05 - $1.12
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $1.00
Resistance Level $1.16
Current Trend Strong Uptrend
Technical data as of Sep 17, 2026

Fundamental Context

Forward P/E (Next Year Est.) -10.10
Wall Street Target $5.50 (+434.0%)
Revenue Growth (YoY) -61.3%
Profit Margin -246.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 18, 2026 11:13 AM ET
Data refreshes hourly during market hours. Next update: 12:13 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for LCTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 57 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$285 46 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$34 60 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$36 44 HOLD
VRDN
Viridian Therapeutics Inc
STRONG BUY
16 analysts
$37 67 BUY

More Analysis for LCTX

LCTX Technical Chart LCTX Price Prediction LCTX Earnings Date LCTX Investment Advisor LCTX Fair Price Analyzer LCTX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals